A trial for histopathological subclassification of papillary cystadenoma lymphomatosum by 99Tcm-pertechnetate in a patient with multiple bilateral lesions of the parotid glands

Dentomaxillofac Radiol. 2005 Jul;34(4):218-21. doi: 10.1259/dmfr/96257752.

Abstract

Objectives: The purpose of this report was to evaluate the possibility of subclassification of papillary cystadenoma lymphomatosum (PCL) with 99Tc(m)-pertechnetate.

Methods: A patient with multiple bilateral PCLs in the parotid glands was examined by using 99Tc(m)-pertechnetate.

Results: All PCLs of the present case, which were diagnosed as the subtype-II histopathologically, showed similar radioactive indexes in scintigraphy (the mean radioactive index = 3.62), although tumours were different in size. The mean radioactive index corresponded well with that from four cases of subtype-II of our previous report (the mean radioactive index = 3.84).

Conclusions: The results of the present report suggest a possibility of histopathological subclassification of PCLs into subtypes by 99Tc(m)-pertechnetate scintigraphy.

Publication types

  • Case Reports

MeSH terms

  • Adenolymphoma / classification
  • Adenolymphoma / diagnostic imaging
  • Adenolymphoma / pathology*
  • Humans
  • Male
  • Middle Aged
  • Parotid Gland / diagnostic imaging
  • Parotid Gland / pathology
  • Parotid Neoplasms / classification
  • Parotid Neoplasms / diagnostic imaging
  • Parotid Neoplasms / pathology*
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Sodium Pertechnetate Tc 99m*

Substances

  • Radiopharmaceuticals
  • Sodium Pertechnetate Tc 99m